• 1105 Citations
  • 17 h-Index
19952020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 1980-1987 M.D., Medicine,  National Defense Medical Center, Taiwan

Experience

  • 2016.02- Associate Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
  • 2012.08-2016.01 Assistant Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
  • 2001.02-2012.07 Instructor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
  • 2000.12- Director, Division of Infectious Disease, Department of Internal Medicine, Taipei Municipal Wanfang Hospital
  • 1997.04-2000.11 Chief of Infectious disease, Ta-Li Zen-Ai hospital, Tai-Chung
  • 1995.11-1997.04 Attending Physician, Division of Infectious Disease, Tri-Service General Hospital
  • 1990.11-1995.11 Resident  Physician, Department of Internal Medicine, Taipei Veterans General Hospital

Awards

  • 2011 Excellent reaserch programUniversity
  • 2004 The best attending physician

Research Interests

  • Clinical infectious disease
  • Clinical Microbiology
  • Infection control

Fingerprint Dive into the research topics where Wen-Sen Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

  • 1105 Citations
  • 17 h-Index
  • 109 Article
  • 10 Letter
  • 1 Conference contribution
  • 1 Editorial

A double-blind, randomized controlled trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with the adjuvant LTh(αK): A phase II study

Pan, S. C., Hsu, W. T., Lee, W. S., Wang, N. C., Chen, T. J., Liu, M. C., Pai, H. C., Hsu, Y. S., Chang, M. & Hsieh, S. M., Jan 29 2020, In : Vaccine. 38, 5, p. 1048-1056 9 p.

Research output: Contribution to journalArticle

  • 1 Citation (Scopus)
    Open Access
    1 Citation (Scopus)

    Reply to Zhou and Wu, "be careful with adverse events caused by cefoperazone-sulbactam"

    Liu, J. W., Chen, Y. H., Lee, W. S., Lin, J. C., Huang, C. T., Lin, H. H., Liu, Y. C., Chuang, Y. C., Tang, H. J., Chen, Y. S., Ko, W. C., Lu, M. C. & Wangn, F. D., Jan 27 2020, In : Antimicrobial Agents and Chemotherapy. 64, 2, e02028.

    Research output: Contribution to journalLetter

    Open Access
  • 5 Citations (Scopus)